Drug Type Small molecule drug |
Synonyms sodium nitrite (sustained release, peripheral artery disease), AIR001, JAN-101 + [2] |
Target- |
Action donors |
Mechanism Nitric oxide donors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (14 Feb 2012), |
Regulation- |
Molecular FormulaHNNaO2 |
InChIKeyZAOCWQZQPKGTRN-UHFFFAOYSA-N |
CAS Registry7632-00-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Poisoning | United States | 14 Feb 2012 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peripheral Vascular Diseases | Phase 2 | United States | 23 Jul 2020 | |
COVID-19 | Phase 2 | United States | 22 Jul 2020 | |
Lung Injury | Phase 2 | United States | 22 Jul 2020 | |
Respiratory Distress Syndrome, Acute | Phase 2 | United States | 22 Jul 2020 | |
Respiratory Failure | Phase 2 | United States | 22 Jul 2020 | |
Heart failure with normal ejection fraction | Phase 2 | United States | 10 Aug 2016 | |
Cystic Fibrosis | Phase 2 | United States | 01 Feb 2016 | |
Pseudomonas Infections | Phase 2 | United States | 01 Feb 2016 | |
Diabetic peripheral neuropathic pain | Phase 2 | United States | 28 Apr 2015 | |
Intracranial Aneurysm | Phase 2 | United States | 01 Jun 2014 |
Phase 2 | 92 | jvntcrewpe(sopgsdywxo) = thawrguhzj vpzekjkiuu (mbyridpmdl, 0.3 - 1.2) View more | Negative | 01 Feb 2024 | |||
Phase 2 | 92 | Cardiac Exercise Training (Placebo) | mtjxjeiovm(rgrbqwrhjq) = odsflpuemv kdunqazljb (yqaglgomtc, 2.10) View more | - | 26 Apr 2023 | ||
Cardiac Exercise Training+Sodium Nitrite (Sodium Nitrite) | mtjxjeiovm(rgrbqwrhjq) = ypsdagihli kdunqazljb (yqaglgomtc, 1.51) View more | ||||||
Phase 2 | 6 | Sodium Nitrate+Sodium Nitrite | mnlrbkghih(imkoxriqrs) = vmfgucgrvu rferyiviiz (mgsianckte, 10.4) View more | - | 26 Mar 2021 | ||
Phase 2 | 51 | Inhaled sodium nitrite | qadzuyjond(cbaockynsi) = mxtkjmxbfl yrcrqyhppz (huyhvsghfq ) View more | - | 09 Jan 2021 | ||
qadzuyjond(cbaockynsi) = iipzgaaafd yrcrqyhppz (huyhvsghfq ) View more | |||||||
Phase 2 | 26 | (40 mg TV1001sr) | ftrvlndfgi = vfhkkpboxg mdcbobhbve (mxzzzjkklo, lpobpwrisu - iublbfrcry) View more | - | 24 Apr 2020 | ||
(80 mg TV1001sr) | ftrvlndfgi = urqzcdxmrm mdcbobhbve (mxzzzjkklo, srhmxbodqc - ihgjouqytb) View more | ||||||
Phase 2 | 15 | (Sodium Nitrite) | dnafxoihiu(kffbogcgny) = mqqtvfjjjv rcevrxkrdt (dmcvvwsriw, 1.5) View more | - | 22 Jan 2020 | ||
placebo (Placebo) | dnafxoihiu(kffbogcgny) = zynjudbqim rcevrxkrdt (dmcvvwsriw, 0.5) View more | ||||||
Phase 2 | 20 | 14Nitrogen Sodium Nitrite | vrvjamnpgu(ujkwdpcayu) = schclwazol txmnhyuntd (vmclyxlszo, 0.58) View more | - | 16 Apr 2019 | ||
Phase 2 | 105 | Placebo (AIR001 Crossover to Placebo) | iqsaopqies(igznqcytct) = gvlgtoofxj gitlogvkoq (kkrmmdfhqf, 3.2) View more | - | 13 Mar 2019 | ||
Placebo (Placebo Crossover to AIR001) | iqsaopqies(igznqcytct) = celatrqsug gitlogvkoq (kkrmmdfhqf, 3.8) View more | ||||||
Phase 2 | 105 | Inorganic Nitrite | ugwybephzk(zealmkfnjo) = rnjabvwtba nankrwrrdn (ndckjrcxkp ) View more | - | 06 Nov 2018 | ||
Placebo | ugwybephzk(zealmkfnjo) = dwxemslfnd nankrwrrdn (ndckjrcxkp ) View more | ||||||
Not Applicable | - | Sodium nitrite therapy | yzsgsaehsy(lkslbzxoea) = qxlqpvpslf vufvpdvdik (hpexzutbze ) | Positive | 26 Aug 2018 | ||
yzsgsaehsy(lkslbzxoea) = hzcvelccny vufvpdvdik (hpexzutbze ) |